Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Large scale brain proteome profiling of 3xtg mice

ABSTRACT: A large scale profiling of 3xtg mouse brain to invetigate the AD proteomic phenotype.

INSTRUMENT(S):

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Brain

SUBMITTER: Ka Yang

LAB HEAD: Junmin Peng

PROVIDER: PXD053314 | Pride | 2024-06-25

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	PRIDE_sample_information_AD_drug.xlsx	Xlsx
	ad_drug_b2_f001.1.pepXML	Pepxml
	ad_drug_b2_f001.raw	Raw
	ad_drug_b2_f002.1.pepXML	Pepxml
	ad_drug_b2_f002.raw	Raw

Items per page:

1 - 5 of 430

Similar Datasets

Proteome-wide pulse labeling reveals amyloid-impaired protein degradation in Alzheimer’s disease

Project description:We here present a large-scale proteome-wide profiling of protein turnover in Alzheimer's disease mice model. We integrated in vivo pulse-SILAC labeling and TMT multiplexing with novel mass spectrometry to precisely measure protein half-lives.

2024-10-28 | PXD031830 | Pride

A proteomic study of dual-functional degrader in leukemia cell line

Project description:Here we present the proteomic study of WB156, which is a selective and dual-functional degrader against MDM2 and GSPT1, in leukemia cell line Molt4 and MV4;11.

2025-05-24 | PXD031836 | Pride

Evaluation of a Pooling Chemoproteomics Strategy with an FDA-approved Drug Library

Project description:Chemoproteomics is a key platform for characterizing the mode of action (MoA) for compounds, especially for targeted protein degraders such as proteolysis targeting chimerics (PROTACs) and molecular glues. With deep proteome coverage, multiplexed tandem mass tag-mass spectrometry (TMT-MS) can tackle up to 18 samples in a single experiment. Here, we present a pooling strategy to further enhance the throughput, and apply the strategy to an FDA-approved drug library (95 best-in-class compounds). The TMT-MS-based pooling strategy was evaluated in the following steps. First, we demonstrated the capability of TMT-MS by analyzing over 15,000 unique proteins (>12,000 gene products) in HEK293 cells treated with five PROTACs (two BRD/BET degraders and three degraders for FAK, ALK, and BTK kinases). We then introduced a rationalized pooling strategy to separate structurally similar compounds in different pools, and identified the proteomic response to 14 pools from the drug library. Finally, we validated the proteomic response from one pool by re-profiling the cells under individual drug treatment with sufficient replicates. Interestingly, numerous proteins were found to change upon drug treatment, including AMD1, ODC1, PRKX, PRKY, EXO1, AEN and LRRC58 by 7-Hydroxystaurosporine; C6orf64, HMGCR and RRM2 by Sorafenib; SYS1 and ALAS1 by Venetoclax; and ATF3, CLK1 and CLK4 by Palbocilib. Thus, the pooling chemoproteomics screening provides an efficient method for dissecting the molecular targets of compound libraries.

2023-03-11 | PXD033780 | Pride

A chemoproteomic map of compound candidate to arrest cell growth in pancreatic cancer patient-derived organoids

Project description:We here present a proteomic study of drug inhibiting the cell growth of pancreatic cancer patient-derived organoids

2024-05-27 | PXD031663 | Pride

A proteomic study of dual-functional degrader in leukemia cell line

Project description:Here we present the proteomic study of WB156, which is a selective and dual-functional degrader against MDM2 and GSPT1, in leukemia cell line Molt4 and MV4;11

2025-05-23 | PXD055642 | Pride

Chemoproteomic map of compounds candidates to modulate human disease in 293t cells

Project description:We here present a proteomic platform by implementing in-depth proteome profiling technologies to drug discovery and mechanism of action study.

2025-09-18 | PXD059473 | Pride

Lateral ventricle SVZ: 3xTg vs WT

Project description:Transcriptional profiling of the microdissected SVZ from 7-month-old mice Adult neurogenesis is suppressed in the SVZ of 3xTg mice, a model of Alzheimer's disease. To better understand the underlying mechanisms of this suppression, the goals of this experiment were to compare the transcriptional profiles of the SVZ neural stem cell niche in 3xTg-AD mice versus strain controls. We used early middle-aged mice (7-months-old) rather than old mice, in order to identify genetic changes that are not caused secondarily to other degenerative changes occurring in these mice. Two-condition experiment, 3xTg vs WT SVZ. Biological replicates: 4 for each.

2015-08-01 | E-GEOD-60460 | biostudies-arrayexpress

Deep Multilayer Tissue Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression, human data

Project description:The molecular networks underlying Alzheimer’s disease (AD) are not well-defined. We present temporal profiling of >14,000 proteins and >34,000 phosphosites at the asymptomatic and symptomatic stages of AD, deep proteomics analysis of transgenic mouse models.

2019-11-11 | PXD007985 | Pride

Tetraspanin-enriched Membrane Domains Regulate Vascular Leakage by Membrane Cholesterol Accessibility to Balance Antagonistic GTPases.

Project description:As an endothelium destabilizer, CD82 facilitates vascular leakage by disrupting endothelial barrier and inhibiting its recovery during inflammation. AC at EC surface primes and promotes vascular leakage, mediates the effect of CD82 or TEMD on inflammation, and can be regulated specifically by i) tetraspanins or TEMDs, ii) ORP-mediated transfer of cholesterol, iii) environmental cholesterol, and iv) statin. Thus, tetraspanin-AC interaction and subcellular cholesterol compartmentalization tune the balances between antagonistic signaling axes of Cdc42 versus RhoA, to alter vascular leakage in inflammation. Equally important, we demonstrated anti-vascular leakage and anti-inflammation roles of i) AC reduction and ii) FARP1-Cdc42 elevation/activation in animal models, with promising translational and clinical prospects.

2025-06-19 | PXD065001 | Pride

Proteomic Profiling of the Hippocampus in Lithium-Deficient 3xTg-AD Mice

Project description:This proteomics experiment aimed to identify proteins whose abundance is altered by lithium deficiency in the context of Alzheimer's disease pathology in mice. Female homozygous 3xTg-AD mice were continuously fed either a lithium-deficient or a control diet from 6 to 15 months of age. At the end of the treatment period, mice (n=4 per group) were sacrificed, perfused transcardially with PBS, and their hippocampi were extracted for proteomic analysis.

2025-06-09 | PXD063039 | Pride